Despite little being known about these enzymes in cancer, the CHAC2 isoform has been classified as a tumor suppressor gene in gastric and colorectal cancer studies, correlating CHAC2 downregulation with more aggressive cancer phenotypes and its activation with cancer cells poor survival [117]. The gene discussed is CHAC2; the disease is colorectal cancer.